Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Cardiovascular News

News
Warfarin Tied to Progressive Coronary Artery Calcification
07/24/2017
Research recently examined the effects of warfarin on coronary arteries regardless of changes in atheroma volume, concomitant statin use or renal function.
Research recently examined the effects of warfarin on coronary arteries regardless of changes in atheroma volume, concomitant statin use or renal function.
Research recently examined the...
07/24/2017
Pharmacy Learning Network

Advertisement

News
Study Suggests Caution in SPRINT-Like BP Targets in Elderly
07/19/2017
For some older adults with hypertension, striving for SPRINT recommended blood pressure goals may result in adverse events. 
For some older adults with hypertension, striving for SPRINT recommended blood pressure goals may result in adverse events. 
For some older adults with...
07/19/2017
Annals of Long-Term Care
News
PCI Can Benefit Some at Age 90 and Older
07/12/2017
Recent research examined the risks and benefits of percutaneous coronary intervention in patients aged 90 and older.
Recent research examined the risks and benefits of percutaneous coronary intervention in patients aged 90 and older.
Recent research examined the...
07/12/2017
Pharmacy Learning Network
News
Underprescribing Leads to Thousands of Preventable Strokes Annually
05/15/2017
Research examined patients with atrial fibrillation at an increased risk of stroke because they are not receiving oral anticoagulation.
Research examined patients with atrial fibrillation at an increased risk of stroke because they are not receiving oral anticoagulation.
Research examined patients with...
05/15/2017
First Report Managed Care

Advertisement

News
Hospitals Performing TAVR Keep Readmissions, Costs Low
05/12/2017
Research found that hospitals performing a higher volume of transcatheter aortic valve replacements have lower 30-day readmission rates and lower costs.
Research found that hospitals performing a higher volume of transcatheter aortic valve replacements have lower 30-day readmission rates and lower costs.
Research found that hospitals...
05/12/2017
First Report Managed Care
News
Genetics-Based Dosing Strategies
05/11/2017
Brian F. Gage, MD, MSc, professor of medicine at Washington University, discusses how genetics-based dosing may hold promise for improving standard dosing methods.
Brian F. Gage, MD, MSc, professor of medicine at Washington University, discusses how genetics-based dosing may hold promise for improving standard dosing methods.
Brian F. Gage, MD, MSc,...
05/11/2017
Pharmacy Learning Network
News
Yale-New Haven Health System Designates Tirofiban as the Primary Glycoprotein IIb/IIIa Inhibitor
05/01/2017
Samuel S. Hahn, MD, FACC, FSCAI, and Ralph J. Riello III, PharmD, BCPS, talk about the selection of tirofiban as a preferred glycopotein IIb/IIIa inhibitor.
Samuel S. Hahn, MD, FACC, FSCAI, and Ralph J. Riello III, PharmD, BCPS, talk about the selection of tirofiban as a preferred glycopotein IIb/IIIa inhibitor.
Samuel S. Hahn, MD, FACC, FSCAI,...
05/01/2017
Pharmacy Learning Network

Advertisement

News
Bivalirudin in Briefer PCI May Boost Stent Thrombosis Risk
03/07/2017
A study identified a novel risk factor for acute stent thrombosis in patients treated with bivalirudin.
A study identified a novel risk factor for acute stent thrombosis in patients treated with bivalirudin.
A study identified a novel risk...
03/07/2017
Pharmacy Learning Network
News
Bayer`s Blood Thinner also Effective for Artery Disease
02/08/2017
Bayer's best-selling blood-thinner may also be effective at preventing heart attack and stroke in patients with coronary artery disease or peripheral artery disease.
Bayer's best-selling blood-thinner may also be effective at preventing heart attack and stroke in patients with coronary artery disease or peripheral artery disease.
Bayer's best-selling...
02/08/2017
Pharmacy Learning Network
News
Study Finds No Safety Concerns for Sitagliptin Use in Elderly
02/03/2017
Sitagliptin does not appear to increase the risk of cardiovascular events in patients with type 2 diabetes who are 75 years or older, according to results from the TECOS trial.
Sitagliptin does not appear to increase the risk of cardiovascular events in patients with type 2 diabetes who are 75 years or older, according to results from the TECOS trial.
Sitagliptin does not appear to...
02/03/2017
Annals of Long-Term Care

Advertisement

Advertisement

Advertisement

Advertisement

What's Trending?

eINTERACT: The Effect of Health Information Technology on Nurse-to-Provider Communication and Avoidable Hospital Transfers
09/16/2019
This quality improvement project incorporated eINTERACT clinical decision support tools into the electronic health record at two subacute rehabilitation centers in New Jersey in an effort to enhance nurse-to-provider communication and reduce...
This quality improvement project incorporated eINTERACT clinical decision support tools into the electronic health record at two subacute rehabilitation centers in New Jersey in an effort to enhance nurse-to-provider communication and reduce...
This quality improvement project...
09/16/2019
Annals of Long-Term Care
News
Narcotic Pain Reliever Recalled
04/20/2018
A prescription opioid analgesic used to treat moderate to severe pain is being recalled.
A prescription opioid analgesic used to treat moderate to severe pain is being recalled.
A prescription opioid analgesic...
04/20/2018
Pharmacy Learning Network
News
FDA Reviews Pregnancy and Pain Med Studies
01/12/2015
The FDA issued a safety announcement on January 9 regarding the use of prescription and over-the-counter pain medications in pregnant women.
The FDA issued a safety announcement on January 9 regarding the use of prescription and over-the-counter pain medications in pregnant women.
The FDA issued a safety...
01/12/2015
Pharmacy Learning Network
News
CVS Caremark Study Finds Value Based Insurance Designs Can Increase Adherence in Diabetes Patients
02/16/2010
02/16/2010
First Report Managed Care
News
FDA Targets Firms Illegally Selling Cannabidiol Products
11/27/2019
More than a dozen companies received warning letters from the US Food and Drug Administration about illegally selling products containing cannabidiol.
More than a dozen companies received warning letters from the US Food and Drug Administration about illegally selling products containing cannabidiol.
More than a dozen companies...
11/27/2019
Pharmacy Learning Network

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use